Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Poll

More »
Jun 08, 2009

Reimbursing Molecular Diagnostics

Is insufficient reimbursement holding molecular diagnostic tests back from reaching the clinic?

Yes
 
  58.6%
No
 
  11.4%
Undecided
 
  30.0%

Suggest a Poll
More Polls » View Results »
Molecular diagnostics is one of the fastest growing areas of biotechnology product development. Once firmly rooted in the research side of the business, DNA testing is quickly making headway in the clinical arena in, for example, prenatal, tissue typing, and inherited disease applications. However, some industry analysts maintain that concern over reimbursement is acting as a roadblock to an even greater penetration of molecular diagnostic tests in the medical field. Do you agree?

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll